Search research articles
Contact Us
Filters
Showing results (81-90 of 109) with videos related to
Page
of 11
Sort By:
Transplantation
|
October 14, 2006
A comparison of the effects of C2-cyclosporine and C0-tacrolimus on renal function and cardiovascular risk factors in kidney transplant recipients
S Joseph Kim, G V Ramesh Prasad, Michael Huang, et al.
American Journal of Nephrology
|
December 20, 2003
Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy
W Kline Bolton, Daniel C Cattran, Mark E Williams, et al.
Kidney International
|
August 2, 2024
Application of the updated International IgA Nephropathy Prediction Tool in children one or two years post-biopsy
Sean J Barbour, Rosanna Coppo, Lee Er, et al.
Kidney International
|
January 21, 2011
Persistent proteinuria and dyslipidemia increase the risk of progressive chronic kidney disease in lupus erythematosus
Heather N Reich, Dafna D Gladman, Murray B Urowitz, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
August 14, 2010
Rituximab therapy in idiopathic membranous nephropathy: a 2-year study
Fernando C Fervenza, Roshini S Abraham, Stephen B Erickson, et al.
Kidney International
|
December 17, 2013
Personalized prophylactic anticoagulation decision analysis in patients with membranous nephropathy
Taewoo Lee, Andrea K Biddle, Sofia Lionaki, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
January 13, 2019
Proteinuria Reduction as a Surrogate End Point in Trials of IgA Nephropathy
Aliza Thompson, Kevin Carroll, Lesley A Inker, et al.
Canadian Journal of Kidney Health and Disease
|
April 22, 2022
The Canadian Glomerulonephritis Registry (CGNR) and Translational Research Initiative: Rationale and Clinical Research Protocol
Ainslie M Hildebrand, Moumita Barua, Sean J Barbour, et al.
Clinical Pharmacokinetics
|
February 15, 2021
Evaluation of the Pharmacokinetics and Exposure-Response Relationship of Dapagliflozin in Patients without Diabetes and with Chronic Kidney Disease
Annemarie B van der Aart-van der Beek, Jeroen V Koomen, Claire C J Dekkers, et al.
Journal of the American Society of Nephrology : JASN
|
July 8, 2015
Integrative Genomics Identifies Novel Associations with APOL1 Risk Genotypes in Black NEPTUNE Subjects
Matthew G Sampson, Catherine C Robertson, Sebastian Martini, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 109) with videos related to
Sort By:
Page
of 11
Transplantation
|
October 14, 2006
A comparison of the effects of C2-cyclosporine and C0-tacrolimus on renal function and cardiovascular risk factors in kidney transplant recipients
S Joseph Kim, G V Ramesh Prasad, Michael Huang, et al.
American Journal of Nephrology
|
December 20, 2003
Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy
W Kline Bolton, Daniel C Cattran, Mark E Williams, et al.
Kidney International
|
August 2, 2024
Application of the updated International IgA Nephropathy Prediction Tool in children one or two years post-biopsy
Sean J Barbour, Rosanna Coppo, Lee Er, et al.
Kidney International
|
January 21, 2011
Persistent proteinuria and dyslipidemia increase the risk of progressive chronic kidney disease in lupus erythematosus
Heather N Reich, Dafna D Gladman, Murray B Urowitz, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
August 14, 2010
Rituximab therapy in idiopathic membranous nephropathy: a 2-year study
Fernando C Fervenza, Roshini S Abraham, Stephen B Erickson, et al.
Kidney International
|
December 17, 2013
Personalized prophylactic anticoagulation decision analysis in patients with membranous nephropathy
Taewoo Lee, Andrea K Biddle, Sofia Lionaki, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
January 13, 2019
Proteinuria Reduction as a Surrogate End Point in Trials of IgA Nephropathy
Aliza Thompson, Kevin Carroll, Lesley A Inker, et al.
Canadian Journal of Kidney Health and Disease
|
April 22, 2022
The Canadian Glomerulonephritis Registry (CGNR) and Translational Research Initiative: Rationale and Clinical Research Protocol
Ainslie M Hildebrand, Moumita Barua, Sean J Barbour, et al.
Clinical Pharmacokinetics
|
February 15, 2021
Evaluation of the Pharmacokinetics and Exposure-Response Relationship of Dapagliflozin in Patients without Diabetes and with Chronic Kidney Disease
Annemarie B van der Aart-van der Beek, Jeroen V Koomen, Claire C J Dekkers, et al.
Journal of the American Society of Nephrology : JASN
|
July 8, 2015
Integrative Genomics Identifies Novel Associations with APOL1 Risk Genotypes in Black NEPTUNE Subjects
Matthew G Sampson, Catherine C Robertson, Sebastian Martini, et al.
Page
of 11